The influence of covid 19 on screening and management of colorectal cancers, case study of the agadir oncology centre

Abstract

Colorectal cancer (CRC) is the 3rd cancer in the world after lung cancer and breast cancer, its incidence has increased over the past decade. It occupies the first place among digestive cancers in Morocco (40.3%), However, given the absence of a national cancer registry, there is no epidemiological data on all of Morocco. Based on data from the Greater Casablanca Cancer Registry (RCRC), the annual national cancer incidence is estimated at 101.7 new cases per 100,000 populations, which would equate to 30,500 new cancer cases each year. In terms of frequency by sex, colorectal cancer is the second most common cancer in women and the third most common in men. It has significant human and financial consequences. Despite therapeutic and preventive advances, which have reduced mortality due to colorectal cancer, colorectal cancer still kills people around the world. However, the advent of the Covid 19 pandemic has caused a delay in screening and a disruption in management, this article summarizes the main results of this delay and the risks on the evolution of colorectal cancers. The study is carried out at the Regional Oncology Centre of Agadir (CRO). Keywords: screening, management, Covid 19, colorectal cancer.